QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 west-pharmaceutical-servs-q1-2024-adj-eps-156-beats-126-estimate-sales-695400m-beat-670303m-estimate

West Pharmaceutical Servs (NYSE:WST) reported quarterly earnings of $1.56 per share which beat the analyst consensus estimate o...

 sp-reclaims-5000-as-disappointing-retail-sales-put-fed-cuts-back-on-track-small-caps-shine-whats-driving-markets-thursday

US stocks surge on strong earnings and speculation of Fed rate cuts. S&P 500 rebounds past 5000, Nasdaq 100 pauses. Small c...

 why-herbalife-shares-are-trading-lower-by-around-36-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Herbalife Ltd. (NYSE: HLF) fell sharply in today’s session following weak quarterly earnings.

 west-pharmaceuticals-2024-outlook-cautious-analysts-remain-optimistic

West Pharmaceutical Services reports Q4 2023 adjusted EPS at $1.83, surpassing consensus. Quarterly sales hit $732 million miss...

 west-pharmaceutical-servs-q4-adjusted-eps-183-beats-178-estimate-sales-73200m-miss-73947m-estimate

West Pharmaceutical Servs (NYSE:WST) reported quarterly earnings of $1.83 per share which beat the analyst consensus estimate o...

 earnings-scheduled-for-february-15-2024

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on rev...

 keybanc-maintains-overweight-on-west-pharmaceutical-servs-raises-price-target-to-470

Keybanc analyst Paul Knight maintains West Pharmaceutical Servs (NYSE:WST) with a Overweight and raises the price target fro...

 transdigm-west-pharmaceutical-thermo-fisher-scientific-and-a-tech-company-on-cnbcs-final-trades

On CNBC’s "Halftime Report Final Trades," Steve Weiss of Short Hills Capital Partners named TransDigm Group Incorporate...

 west-receives-fda-510k-clearance-for-vial2bag-advanced-13mm-admixture-device

West expands administration systems portfolio with new smaller size needle-free admixture device for immediate use IV drug tran...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION